Intrinsic Value of S&P & Nasdaq Contact Us

Cingulate Inc. CINGW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
32/100
1/5 Pass
SharesGrow Intrinsic Value
$2,260,930.00
+10766333233.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cingulate Inc. (CINGW) has a negative trailing P/E of -1.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -69.61%, forward earnings yield 5,000.00%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 0.0 — analysts expect a return to profitability with estimated EPS of $1.16 for FY2029.
  • Trailing Earnings Yield -69.61% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 5,000.00% as earnings recover.

Overall SharesGrow Score: 30/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
32/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — CINGW

Valuation Multiples
P/E (TTM)-1.4
Forward P/E0.0
PEG RatioN/A
Forward PEG0.00
P/B Ratio12.85
P/S Ratio0.00
EV/EBITDA-1.6
Per Share Data
EPS (TTM)$-4.13
Forward EPS (Est.)$1.16
Book Value / Share$0.46
Revenue / Share$0.00
FCF / Share$2,508.27
Yields & Fair Value
Earnings Yield-69.61%
Forward Earnings Yield5,000.00%
Dividend Yield0.00%
SharesGrow IV$2,260,930.00 (+10766333233.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -130.8 0.00 2,451.43 0.00 -
2020 -210.2 2.22 1,168.17 0.00 -
2021 -45.1 -0.13 44.93 0.00 -
2022 -19.2 0.44 87.40 0.00 -
2023 -8.8 -0.01 -30.24 0.00 -
2024 -1.2 0.01 2.52 0.00 -
2025 -1.0 0.02 9.40 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-242.89 $0.00 $-11.45M -
2020 $-154.57 $0.00 $-7.28M -
2021 $-440.14 $0.00 $-20.74M -
2022 $-378.81 $0.00 $-17.85M -
2023 $-311.99 $0.00 $-23.53M -
2024 $-8.80 $0.00 $-15.55M -
2025 $-4.13 $0.00 $-22.45M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.71 $-1.71 – $-1.71 $2.39M $2.39M – $2.39M 1
2027 $-1.06 $-1.06 – $-1.06 $7.51M $7.43M – $7.58M 1
2028 $-0.56 $-0.56 – $-0.56 $21.01M $21.01M – $21.01M 1
2029 $1.16 $1.16 – $1.16 $44.12M $44.12M – $44.12M 1
2030 $3.00 $3.00 – $3.00 $70.43M $70.43M – $70.43M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message